NASH Clinical Trial
Nonalcoholic Steatohepatitis (NASH)
Are you a Type 2 Diabetic or overweight?
If so, then you may have NASH since it is found in up to 80% of people who have type 2 diabetes and up to 90% of people who are overweight with a BMI over 30.
Considering joining this paid clinical trial to accelerate treatment options!
NASH Clinical Trial
Nonalcoholic Steatohepatitis (NASH)
Are you a Type 2 Diabetic or overweight?
If so, then you may have NASH since it is found in up to 80% of people who have type 2 diabetes and up to 90% of people who are overweight with a BMI over 30.
Considering joining this paid clinical trial to accelerate treatment options!
What is NASH?
Nonalcoholic fatty liver disease (NAFLD) is a condition in which the liver has an abundance of fat build up, and is not caused by the over-consumption of alcohol. There are two forms of NAFLD: fatty liver (steatosis), and Nonalcoholic Steatohepatitis (NASH).
NASH is a form of NAFLD in which you have hepatitis — inflammation of the liver —and liver cell damage, in addition to fat in your liver. If uncontrolled, this inflammation and liver cell damage can cause fibrosis, and eventually lead to cirrhosis or liver cancer. NASH is a chronic, but silent disease and most individuals live with it for several years before seeing symptoms.
What Causes NASH?
The main cause of NASH is due to dietary habits. There are many factors that play a role in this correlation including gender & age, socioeconomic status, rural vs city living, etc.
The disease is more common in people with preexisting conditions like obesity, type 2 diabetes/prediabetes, and other metabolic symptoms.
If you suspect NASH has developed or is developing in your liver, then consider signing up for this paid clinical trial.
Study Compensation
You will be compensated for your time in the study. You will receive ≥$100 after each completed visit. It is not expected to cost you to participate in the study. The study drug will be provided to you at no charge and you will not be charged for any procedure performed for this study.
You may also be reimbursed for reasonable expenses such as travel cost for attending the study visits and/or parking at the hospital, as well as a night at the hotel for the visit with PK samples if needed.
You will be reimbursed following each completed visit.
- Between 30 and 40 percent of adults in the United States have NAFLD and recent studies have shown that NAFLD may itself increase the risk of heart disease.1
- It's estimated that 20 percent of people with NAFLD have NASH.1
- There was a 170% increase in cases of NASH on the liver transplant waiting list in USA from 2004–13.2
- NAFLD is found in up to 80 percent of people who have type 2 diabetes and up to 90 percent of people who are obese.1
- 1. “Definition & Facts of NAFLD & NASH.” National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, Nov. 2016, www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts. 2. Maurice, James, and Pinelopi Manousou. “Non-Alcoholic Fatty Liver Disease.” Clinical Medicine (London, England), Royal College of Physicians, June 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6334080/.
- 2. Maurice, James, and Pinelopi Manousou. “Non-Alcoholic Fatty Liver Disease.” Clinical Medicine (London, England), Royal College of Physicians, June 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6334080/.